Evommune, Inc. (EVMN)
NYSEHealth CareBiotechnologySnapshot 2026-09-04
$12.27+2.25%
Close 2026-09-04 · 1-day change
NYSEHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · EVMN
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenues | — | 13.0 | 7.0 | — |
| Operating Expenses & Income | ||||
| R&D Expenses | 83.8 | 74.0 | 64.2 | — |
| Operating Income | (101.9) | (81.1) | (70.0) | — |
| Earnings from Continuing Operations | ||||
| Interest & Investment Income | 7.2 | 3.3 | 3.2 | — |
| Asset Writedown | — | — | 0.0 | — |
| EBT, Incl. Unusual Items | — | (68.9) | (68.3) | — |
| Income Tax Expense | — | — | 0.0 | — |
| Net Income | ||||
| Net Income | (94.7) | (68.9) | (66.8) | — |
| Per Share | ||||
| Basic EPS | (2.62) | (11.22) | (45.29) | — |
| Diluted EPS | (2.62) | (11.22) | (45.29) | — |
| Basic Weighted Avg Shares | 36.1 | 6.1 | 1.5 | — |
| Diluted Weighted Avg Shares | 36.1 | 6.1 | 1.5 | — |
| Supplemental | ||||
| EBITDA | — | (79.7) | (68.7) | — |
| EBIT | (101.9) | (81.1) | (70.0) | — |
| Effective Tax Rate | — | — | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.